Featured Research

from universities, journals, and other organizations

Improving Severe Trauma Survival Rates

Date:
July 8, 2008
Source:
University of California - Irvine
Summary:
A method of resuscitation for victims of severe traumatic injury will be the subject of a clinical trial to be undertaken by a team of Orange County emergency care providers.

ROC responders.
Credit: Image courtesy of University of California - Irvine

A method of resuscitation for victims of severe traumatic injury will be the subject of a clinical trial to be undertaken by a team of Orange County emergency care providers.

The Orange County Resuscitation Outcomes Consortium will include UC Irvine, Orange County Health Care Agency, Mission Hospital, Western Medical Center Santa Ana, Orange County Fire Authority, and fire departments from other Orange County cities.

The ROC group will conduct and oversee a clinical effort in which people who receive severe traumatic injury – such as in a serious motor vehicle accident – will be treated with hypertonic saline solution as part of theemergency medical response. Previous studies have shown that hypertonic saline safely and effectively decreases inflammation, especially with brain trauma, and that survival outcomes potentially can improve.

Orange County ROC is part of a National Institutes of Health federally funded study involving emergency medical services agencies, public safety agencies, regional hospitals, community healthcare institutions and medical centers in 11 regions in the United States and Canada, and as many as 15,000 patients over a three-year period. The overall goal is to learn the best ways to improve survival from cardiac arrest and severe trauma. Orange County will participate only in the trauma portion of the study.

“Clinical research has made great advances in medical care over the past quarter century, but there have been few similar advances in the area of emergency response care. The ROC study represents the greatest effort yet to make advances in this area and help save the lives of the thousands of Americans each year who otherwise would die from their traumatic injuries,” said Dr. David Hoyt, the John E. Connolly, M.D.,Chair of Surgery at UC Irvine Medical Center and Orange County ROC study leader. Hoyt, one of the nation’s top trauma surgeons, leads the ROC trauma trials at the national level.

The trial is especially important, Hoyt added, because unintended accidents are the fourth leading cause of death in the United States, according to the National Center for Health Statistics. Nearly 43,000 Americans die each year in motor vehicle traffic accidents alone.

“The ROC study is essential to help determine how these new treatments can be used to save more lives,” said Dr. Ken Miller, Orange County Fire Authority medical director. “Because these interventions are time sensitive, they will be initiated by paramedics trained in the study protocol and be further evaluated during in-hospital patient treatment and recovery.”

The Orange County ROC trial will differ from other clinical trials because many of its participants will not be able to give consent or have family nearby to do so. Consent is required for all clinical studies, although federal law allows for exceptions if the safety of the product to be used has been proven in previous trials and if study leaders conduct community outreach discussions and opt-out measures for those who do not want to participate.


Story Source:

The above story is based on materials provided by University of California - Irvine. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Irvine. "Improving Severe Trauma Survival Rates." ScienceDaily. ScienceDaily, 8 July 2008. <www.sciencedaily.com/releases/2008/07/080708122439.htm>.
University of California - Irvine. (2008, July 8). Improving Severe Trauma Survival Rates. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/07/080708122439.htm
University of California - Irvine. "Improving Severe Trauma Survival Rates." ScienceDaily. www.sciencedaily.com/releases/2008/07/080708122439.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins